Illumina Disappoints

October 28, 2009 10:37 AM |

Illumina Inc. (Nasdaq: ILMN) reversed year ago losses of 8 cents per share to post a profit of 12 cents per share but the results fell short of estimates and the genetic analysis instrument maker forecast disappointing fourth quarter income. The stock price plunged $8.07 to $33.59.

 

Tags:

Search

About this Entry

This page contains a single entry by published on October 28, 2009 10:37 AM.

Psychiatric Solutions Falls Short was the previous entry in this blog.

SEC Investigating Apollo Group is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12